PURPOSE OF REVIEW: The worldwide prevalence of obesity and its associated metabolic and cardiovascular disorders has risen dramatically during the past two decades. Our objective is to review the mechanisms that link obesity with hypertension and altered kidney function. RECENT FINDINGS: Current evidence suggests that excess weight gain may be responsible for 65-75% of the risk for essential hypertension. Abnormal renal pressure natriuresis, due initially to increased renal tubular sodium reabsorption, is a key factor linking obesity with hypertension. Obesity increases renal sodium reabsorption by activating the renin-angiotensin and sympathetic nervous systems, and by altering intrarenal physical forces. Adipose tissue functions as an endocrine organ, secreting hormones/cytokines (e.g. leptin) that may activate the sympathetic nervous system and alter kidney function. Excess visceral adipose tissue may physically compress the kidneys, increasing intrarenal pressures and tubular reabsorption. Sustained obesity eventually causes structural changes in the kidneys and loss of nephron function, further increasing arterial pressure and leading to severe renal disease in some cases. SUMMARY: Despite considerable progress in understanding the pathophysiology of obesity, there are still no specific guidelines for the treatment of obesity hypertension other than weight reduction. Special considerations for obese hypertensive patients, in addition to controlling blood pressure, are correcting the metabolic abnormalities and protecting the kidneys from injury. This remains an important area for further research, especially in view of the current 'epidemic' of obesity in most industrialized countries.
PURPOSE OF REVIEW: The worldwide prevalence of obesity and its associated metabolic and cardiovascular disorders has risen dramatically during the past two decades. Our objective is to review the mechanisms that link obesity with hypertension and altered kidney function. RECENT FINDINGS: Current evidence suggests that excess weight gain may be responsible for 65-75% of the risk for essential hypertension. Abnormal renal pressure natriuresis, due initially to increased renal tubular sodium reabsorption, is a key factor linking obesity with hypertension. Obesity increases renal sodium reabsorption by activating the renin-angiotensin and sympathetic nervous systems, and by altering intrarenal physical forces. Adipose tissue functions as an endocrine organ, secreting hormones/cytokines (e.g. leptin) that may activate the sympathetic nervous system and alter kidney function. Excess visceral adipose tissue may physically compress the kidneys, increasing intrarenal pressures and tubular reabsorption. Sustained obesity eventually causes structural changes in the kidneys and loss of nephron function, further increasing arterial pressure and leading to severe renal disease in some cases. SUMMARY: Despite considerable progress in understanding the pathophysiology of obesity, there are still no specific guidelines for the treatment of obesity hypertension other than weight reduction. Special considerations for obese hypertensivepatients, in addition to controlling blood pressure, are correcting the metabolic abnormalities and protecting the kidneys from injury. This remains an important area for further research, especially in view of the current 'epidemic' of obesity in most industrialized countries.
Authors: Stephen C Textor; Monika L Gloviczki; Michael F Flessner; David A Calhoun; James Glockner; Joseph P Grande; Michael A McKusick; Stephen S Cha; Lilach O Lerman Journal: Am J Kidney Dis Date: 2011-11-29 Impact factor: 8.860
Authors: Magdalena Madero; Ronit Katz; Rachel Murphy; Anne Newman; Kushang Patel; Joachim Ix; Carmen Peralta; Suzanne Satterfield; Linda Fried; Michael Shlipak; Mark Sarnak Journal: Clin J Am Soc Nephrol Date: 2017-05-18 Impact factor: 8.237
Authors: Moustafa Sayed; Christopher A Drummond; Kaleigh L Evans; Steven T Haller; Jiang Liu; Zijian Xie; Jiang Tian Journal: Stem Cell Res Date: 2014-04-13 Impact factor: 2.020
Authors: Sarah F Knight; Jeffrey E Quigley; Jianghe Yuan; Siddhartha S Roy; Ahmed Elmarakby; John D Imig Journal: Hypertension Date: 2007-12-24 Impact factor: 10.190
Authors: John E Hall; Daniel W Jones; Jay J Kuo; Alexandre da Silva; Lakshmi S Tallam; Jiankang Liu Journal: Curr Hypertens Rep Date: 2003-10 Impact factor: 5.369
Authors: H E Bays; J M González-Campoy; R R Henry; D A Bergman; A E Kitabchi; A B Schorr; H W Rodbard Journal: Int J Clin Pract Date: 2008-08-04 Impact factor: 2.503